| Primary |
| Colon Cancer |
31.3% |
| Drug Use For Unknown Indication |
12.5% |
| Colorectal Cancer Metastatic |
7.8% |
| Pancreatic Carcinoma |
7.8% |
| Biliary Neoplasm |
6.3% |
| Duodenal Carcinoma Recurrent |
6.3% |
| Eye Infection Toxoplasmal |
6.3% |
| Colon Cancer Metastatic |
4.7% |
| Small Intestine Carcinoma |
4.7% |
| Colorectal Cancer |
3.1% |
| Metastatic Colorectal Cancer |
3.1% |
| Acute Lymphocytic Leukaemia |
1.6% |
| Esophageal Cancer |
1.6% |
| Neoplasm Malignant |
1.6% |
| Neurological Symptom |
1.6% |
|
| Sudden Death |
9.1% |
| Vomiting |
9.1% |
| Cerebrovascular Accident |
4.5% |
| Febrile Neutropenia |
4.5% |
| Hepatic Necrosis |
4.5% |
| Hypersensitivity |
4.5% |
| Malaise |
4.5% |
| Metastases To Liver |
4.5% |
| Neuropathy Peripheral |
4.5% |
| Neurotoxicity |
4.5% |
| Osteonecrosis |
4.5% |
| Pain |
4.5% |
| Pleural Effusion |
4.5% |
| Pneumonia |
4.5% |
| Pulmonary Embolism |
4.5% |
| Pulmonary Oedema |
4.5% |
| Pulmonary Thrombosis |
4.5% |
| Rash |
4.5% |
| Recurrent Cancer |
4.5% |
| Respiratory Failure |
4.5% |
|
| Secondary |
| Colorectal Cancer Metastatic |
32.0% |
| Colorectal Cancer |
11.3% |
| Colon Cancer |
9.3% |
| Acute Lymphocytic Leukaemia |
8.8% |
| Drug Use For Unknown Indication |
5.2% |
| Product Used For Unknown Indication |
4.3% |
| Gastric Cancer |
3.4% |
| Rectal Cancer |
3.3% |
| Prophylaxis |
3.2% |
| Chromosome Analysis Abnormal |
2.9% |
| Colon Cancer Metastatic |
2.8% |
| Oesophageal Cancer Metastatic |
2.3% |
| Metastases To Liver |
2.0% |
| Hypertension |
2.0% |
| Pancreatic Carcinoma |
1.7% |
| B-cell Lymphoma |
1.5% |
| Lymphocytic Leukaemia |
1.2% |
| Adenocarcinoma Gastric |
0.9% |
| Adenocarcinoma |
0.9% |
| Premedication |
0.9% |
|
| Vomiting |
20.5% |
| Sepsis |
7.4% |
| Diarrhoea |
7.1% |
| Neutropenia |
7.1% |
| Thrombocytopenia |
6.2% |
| Pyrexia |
5.5% |
| Respiratory Failure |
5.5% |
| Febrile Neutropenia |
4.6% |
| Toxicity To Various Agents |
4.6% |
| Death |
4.1% |
| Stomatitis |
3.4% |
| White Blood Cell Count Decreased |
3.4% |
| Disease Progression |
3.0% |
| Infection |
3.0% |
| Hypertension |
2.8% |
| Pulmonary Embolism |
2.8% |
| Dyspnoea |
2.5% |
| Sudden Death |
2.3% |
| General Physical Health Deterioration |
2.1% |
| Syncope |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
18.6% |
| Acute Lymphocytic Leukaemia |
12.6% |
| Prophylaxis |
12.5% |
| Rheumatoid Arthritis |
10.0% |
| Colon Cancer |
7.9% |
| Colorectal Cancer |
6.2% |
| Colorectal Cancer Metastatic |
5.6% |
| Colon Cancer Metastatic |
4.1% |
| Chromosome Analysis Abnormal |
2.9% |
| Drug Use For Unknown Indication |
2.6% |
| Chemotherapy |
2.1% |
| Pain |
1.9% |
| Premedication |
1.9% |
| Rectal Cancer Metastatic |
1.8% |
| Nausea |
1.8% |
| Neoplasm Malignant |
1.8% |
| Rectal Cancer |
1.7% |
| Hypertension |
1.5% |
| Gastric Cancer |
1.3% |
| B-cell Lymphoma |
1.3% |
|
| Death |
15.2% |
| Disease Progression |
15.2% |
| Vomiting |
13.9% |
| Toxicity To Various Agents |
5.6% |
| Thrombocytopenia |
5.0% |
| Urinary Tract Infection |
4.0% |
| Weight Decreased |
4.0% |
| Neutropenia |
3.6% |
| Rash |
3.6% |
| White Blood Cell Count Decreased |
3.6% |
| Pyrexia |
3.3% |
| Sepsis |
3.3% |
| Leukoencephalopathy |
2.6% |
| Off Label Use |
2.6% |
| Renal Failure Acute |
2.6% |
| Throat Irritation |
2.6% |
| Neuropathy Peripheral |
2.3% |
| Pulmonary Embolism |
2.3% |
| Thrombotic Thrombocytopenic Purpura |
2.3% |
| Pancytopenia |
2.0% |
|
